Johnson & Johnson MedTech Acquires Laminar, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Johnson & Johnson (JNJ) transition underway, UBS assesses upcoming analyst day
December 1, 2023 9:05 AM ESTUBS maintained Johnson & Johnson (NYSE: JNJ) at Buy with a $180 per share price target on Friday in its analyst day preview note.
The firm said it expects the company to reiterate its pharma guide, while its MedTech guide will at... More
